Skip to Content

EVR 5 (Everolimus 5 mg)

Pill with imprint EVR 5 is White, Elliptical / Oval and has been identified as Everolimus 5 mg. It is supplied by Breckenridge Pharmaceutical, Inc..

Everolimus is used in the treatment of breast cancer; neuroendocrine carcinoma; pancreatic cancer; organ transplant, rejection prophylaxis; renal angiomyolipoma and belongs to the drug classes mTOR inhibitors, selective immunosuppressants. There is positive evidence of human fetal risk during pregnancy. Everolimus 5 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for EVR 5

Everolimus

Imprint
EVR 5
Strength
5 mg
Color
White
Shape
Elliptical / Oval
Availability
Prescription only
Drug Class
Mtor inhibitors, Selective immunosuppressants
Pregnancy Category
D - Positive evidence of risk
CSA Schedule
Not a controlled drug
Labeler / Supplier
Breckenridge Pharmaceutical, Inc.
Manufacturer
Natco Pharma Ltd.
National Drug Code (NDC)
51991-0822

Get help with Imprint Code FAQs.

Related Images for "EVR 5"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.